Identification of Ccr7 as a major target highlights the complementary value of RIM screening, as this gene does not appear to be subject to mutation or amplification in human cancer, yet is required for CNS metastasis of human leukaemia cells [52]. This evidence concerns the gene CCR7 and cancer.